community-acquired pneumonia
This is the everyday pneumonia people catch while going about ordinary life — at home, at work, on the bus — rather than after spending time in a hospital. Because it arises in the community, the germs responsible are usually the ordinary ones circulating among healthy people, not the tough hospital strains, so first-line antibiotics still tend to work well.
Community-acquired pneumonia is defined as pneumonia developing in someone who has not recently been hospitalized or in a long-term care facility. The most common single cause is pneumococcus, alongside other bacteria such as Haemophilus influenzae and the so-called atypical organisms like Mycoplasma, and a large share is viral, including influenza. Typical features are fever, cough productive of phlegm, breathlessness and a new infiltrate on the chest X-ray.
Management hinges on judging severity. Many patients are treated at home with oral antibiotics and recover within a week or two, while those with low oxygen, confusion, fast breathing or significant illness are admitted for oxygen and intravenous drugs. Choice of antibiotic is guided by local guidelines and resistance patterns, and most people improve within 48 to 72 hours of effective treatment.
An honest caveat: cultures often fail to identify the exact germ, so treatment is frequently started empirically — that is, on best judgment of the likely cause — and adjusted only if a specific pathogen is later found or the patient is not improving.
Vaccination against pneumococcus and influenza substantially lowers the risk of severe community-acquired pneumonia, especially in older adults and those with chronic disease.